Jacquemyn Xander, Van den Eynde Jef, Caldonazo Tulio, Brown James A, Dokollari Aleksander, Serna-Gallegos Derek, Clavel Marie-Annick, Pibarot Philippe, Sultan Ibrahim, Sá Michel Pompeu
Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Department of Cardiothoracic Surgery, Friedrich Schiller University, Jena, Germany.
Interv Cardiol Clin. 2025 Jul;14(3):351-366. doi: 10.1016/j.iccl.2024.09.003.
Self-expanding valves (SEV) and balloon-expandable valves (BEV) for transcatheter aortic valve implantation (TAVI) have their own features. There is a growing interest in long-term outcomes with the adoption of lifetime management in younger patients. To evaluate late outcomes in TAVI with SEV versus BEV, we performed a study-level meta-analysis of reconstructed time-to-event data published by May 31, 2023. We found no statistically significant difference in all-cause death after TAVI with SEV versus BEV. Randomized controlled trials are warranted to validate our results.
用于经导管主动脉瓣植入术(TAVI)的自膨胀瓣膜(SEV)和球囊扩张瓣膜(BEV)各有特点。随着在年轻患者中采用终身管理,人们对长期预后的兴趣日益浓厚。为了评估SEV与BEV在TAVI中的晚期预后,我们对截至2023年5月31日发表的重构事件发生时间数据进行了研究层面的荟萃分析。我们发现,SEV与BEV在TAVI后的全因死亡方面无统计学显著差异。需要进行随机对照试验来验证我们的结果。